On April 18 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On April 17 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On April 16 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for April 16 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
On April 15 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On April 14 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
During the week of April 7-13, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:
The Food and Drug Administration posted a new Compliance Policy Guide for its staff on enforcement criteria for canned ackee, frozen ackee, and other ackee products. Ackee naturally contains a toxin called hypoglycin A, and the fruit has to be processed in certain ways to minimize health risks. The guide (here) tells FDA staff that ackee is considered to be adulterated if it contains hypoglycin A at levels above 100 ppm. In such cases, FDA staff are to refuse entries of imported ackee.
On April 11 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for April 9 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.